Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ark (ARK) vs Enzyme (MLN) Price & Performance

Ark
Enzyme

Price performance

Price movement over the last 24 hours

Key statistics

Ark vs Enzyme — how do they compare? Ark trades at Rp1,879 (market cap Rp613,43M, Rp95,75M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Ark is far larger — about 4.6× Enzyme's market cap, and Ark's circulating supply is 192,4M ARK versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Ark for 29 Days and Enzyme for 28 Days on average.

ARKMLN
Market Cap
Rp613,43MRp134,13M
Volume (24h)
Rp95,75MRp104,56M
Circulating Supply
192,4M ARK3,3M MLN
Typical Hold Time
29 Days28 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ark

ARK is currently trading at Rp1,898 with a market cap of Rp613.43 million, showing a bearish technical signal overall. Key indicators like RSI_6 at 70.08 suggest overbought conditions, while moving averages are bearish. The price is near support at S1 (Rp1,912), indicating potential volatility. No major fundamental updates were found for the token's ecosystem or protocol recently.

Outlook remains cautious due to bearish technicals and limited fundamental catalysts. Opportunities include potential bounces from support levels, but risks involve high volatility and low liquidity. Investors should monitor for any network updates or exchange developments that could impact price action.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.

Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.

Top news

Latest headlines on both assets

About Ark

ARK is a cryptocurrency and blockchain based development platform allowing anyone to create their own fully customizable and interoperable blockchain. The ARK Ecosystem consists of an open-source blockchain technology stack authored in TypeScript programming language.

Read more on ARK

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN